TSS
ICU icon

Two Sigma Securities’s SeaStar Medical ICU Stock Holding History

Two Sigma Securities’s Portfolio ICU Stock Details ICU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-222
Closed -$28.8K – 3177
2023
Q2 		$28.8K Buy
+222
New +$66.4K ﹤0.01% 2462

Other funds holding ICU

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWA
SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.75B AUM 18.02% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Two Sigma Securities's ICU Position: Q3 2023 in Review

Two Sigma Securities sold out of SeaStar Medical (ICU) in Q3 2023, closing a stake of 222 shares — an estimated $28.8K sold.

Two Sigma Securities first reported a position in ICU in Q2 2023 and held it in 1 quarter. The position peaked at $28.8K in Q2 2023. 12 funds tracked by Wall St. Rank hold ICU as of Q3 2023.

  • Two Sigma Securities reported no remaining SeaStar Medical position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Securities sold 222 SeaStar Medical shares in Q3 2023, an estimated $28.8K.
  • Two Sigma Securities first reported a position in SeaStar Medical in Q2 2023 and held it in 1 quarter.
  • Two Sigma Securities's SeaStar Medical position peaked at $28.8K in Q2 2023.
  • 12 funds tracked by Wall St. Rank held SeaStar Medical as of Q3 2023.

Based on Two Sigma Securities's 13F filing for Q3 2023, filed 14 Nov 2023.